AI to diagnose invisible brain abnormalities in children with epilepsy
Posted:
MELD Graph is an AI tool that could drastically change the care of 30,000 patients in the UK and 4 million patients worldwide who have focal cortical dysplasia (FCD) – a leading cause of epilepsy.
The study, published in JAMA Neurology, shows how the tool significantly improves the detection of FCD. And researchers believe that it will speed up diagnosis times, get patients the surgical treatment they need quicker, and reduce costs to the NHS by up to £55,000 per patient.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.